Which species have cited Afoxolaner dosing data?

Afoxolaner dosing in the ExoticRx formulary covers 7 species: Argentine Tegu, Blue-tongue Skink, Boa Constrictor, Corn Snake, Dog (Domestic), Kingsnake, Milk Snake.

Is Afoxolaner a controlled substance?

Afoxolaner is not federally scheduled in the US. Controlled-drug status differs by country — verify your local rules.

What are the side effects of Afoxolaner?

Reported side effects, adverse reactions, and contraindications for Afoxolaner: FDA-approved for dogs. Seizure potential in dogs with neurologic history. Not for use in puppies <8 weeks or <1.8kg. Dogs only (not cats).

How does Afoxolaner work?

Isoxazoline ectoparasiticide blocking GABA and glutamate-gated chloride channels in arthropods. Monthly flea and tick protection.

Afoxolaner

US brand names:NexGard

Calculate dosage

Sourced from published veterinary references. Awaiting credentialed clinical reviewer — our editorial process.

Afoxolaner is dosed at 2.5 mg/kg PO single dose in argentine tegus, per Mendoza-Roldan JA, Perles L, Miuli C, et al. Efficacy and safety of afoxolaner (NexGard) in a collection of captive-bred lizards for the treatment and control of mite infestations. Int J Parasitol Parasites Wildl. 2025;27:101103. Verify against current literature before clinical use.

Drug Class

Antiparasitic

Routes

Indications

Flea and tick preventionMite infestation (Ophionyssus natricis)Snake mite (Ophionyssus natricis) infestation

Mechanism of Action

Side effects & warnings

FDA-approved for dogs. Seizure potential in dogs with neurologic history. Not for use in puppies <8 weeks or <1.8kg. Dogs only (not cats).

Evidence levels across 7 dose rules

Strong×1Moderate×4Weak×2

Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.

Sample dosing (1 of 7 cited rules)

A dog/cat sample is shown here. Cited dosing for all 7 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.

Species	Route	Dose	Frequency	Evidence	Source
Dog (Domestic)	PO	2.5–6.3 mg/kg	q30 days	Strong	Nexgard - Afoxolaner Tablet, Chewable [US Product Label for Dogs]. Boehringer Ingelheim; 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48dd3eaa-18e3-430d-ad40-a964b591fb16 — Plumb's 10th ed printed p.16, Afoxolaner monograph spanning p.16-17.

Backed by 5 published sourcesShow

· Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae). Parasites & Vectors, 2022. DOI 10.1186/s13071-022-05611-1; PMID 36609309; PMCID PMC9825044. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC9825044/
· Mendoza-Roldan JA, Napoli E, Perles L, et al. Afoxolaner (NexGard) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae). Parasit Vectors. 2023;16(1):6. doi:10.1186/s13071-022-05611-1 https://europepmc.org/article/PMC/PMC9825044

Upgrade for Full Details

Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.

View Plans

Mendoza-Roldan JA, Perles L, Miuli C, Larichiutta P, Legrottaglie M, Bezerra-Santos MA, Samarelli R, Berny P, Beugnet F, Otranto D. Efficacy and safety of afoxolaner (NexGard®) in a collection of captive-bred lizards for the treatment and control of mite infestation. Int J Parasitol Parasites Wildl. 2025;27:101103. doi:10.1016/j.ijppaw.2025.101103 https://europepmc.org/article/MED/40606263

· Mendoza-Roldan JA, Perles L, Miuli C, et al. Efficacy and safety of afoxolaner (NexGard) in a collection of captive-bred lizards for the treatment and control of mite infestations. Int J Parasitol Parasites Wildl. 2025;27:101103. doi:10.1016/j.ijppaw.2025.101103 https://europepmc.org/article/PMC/PMC12219374

· Nexgard - Afoxolaner Tablet, Chewable [US Product Label for Dogs]. Boehringer Ingelheim; 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48dd3eaa-18e3-430d-ad40-a964b591fb16 — Plumb's 10th ed printed p.16, Afoxolaner monograph spanning p.16-17.